Home > Boards > US Listed > Biotechs > Halozyme Therapeutics (HALO)

Halozyme Therapeutics Inc, Inst Holders, 1Q 2019 (HALO)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Fred Kadiddlehopper Member Profile
 
Followed By 24
Posts 3,456
Boards Moderated 1
Alias Born 09/22/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/1/2019 7:11:11 PM
Halozyme To Participate In 2019 Cantor Global Healthcare Conference PR Newswire (US) - 9/23/2019 8:00:00 AM
Positive Results Announced From Phase 3 Trial Evaluating Fixed-Dose Subcutaneous Combination Of Perjeta® And Herceptin® Usi... PR Newswire (US) - 9/13/2019 1:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/4/2019 11:21:22 AM
Halozyme To Participate In 2019 Wells Fargo Healthcare Conference PR Newswire (US) - 8/26/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 4:19:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2019 4:13:31 PM
Halozyme Reports Second Quarter 2019 Results PR Newswire (US) - 8/6/2019 4:01:00 PM
Halozyme To Participate In 39th Annual Canaccord Genuity Growth Conference PR Newswire (US) - 7/25/2019 8:00:00 AM
Halozyme To Host Second Quarter 2019 Financial Results Webcast And Conference Call PR Newswire (US) - 7/23/2019 4:01:00 PM
J&J's Janssen Seeks Europe OK For Subcutaneous Darzalex in Multiple Myeloma Dow Jones News - 7/19/2019 7:45:00 AM
Halozyme Announces Janssen Submits Extension Application To European Medicines Agency For Subcutaneous Formulation Of DARZALE... PR Newswire (US) - 7/19/2019 7:00:00 AM
Halozyme Announces First Clinical Dosing In argenx's Phase 1 Trial Of Efgartigimod (ARGX-113) With ENHANZE® Drug Delivery Te... PR Newswire (US) - 7/17/2019 8:00:00 AM
Halozyme Announces Janssen Submits BLA To FDA For Subcutaneous Formulation Of DARZALEX® Utilizing ENHANZE® Technology PR Newswire (US) - 7/12/2019 11:59:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 7/3/2019 4:02:19 PM
Halozyme Announces CRADA With National Institute of Allergy and Infectious Diseases For Use Of ENHANZE® Drug Delivery Techno... PR Newswire (US) - 6/25/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2019 8:20:11 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2019 1:41:16 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/7/2019 5:11:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 4:45:58 PM
Halozyme To Participate In Upcoming Investor Conferences PR Newswire (US) - 6/4/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 5:24:28 PM
Halozyme Announces argenx Has Selected Second Target Under ENHANZE® Technology Collaboration And License Agreement PR Newswire (US) - 5/22/2019 1:05:00 AM
Post-effective Amendment to an S-8 Filing (s-8 Pos) Edgar (US Regulatory) - 5/14/2019 5:11:52 PM
Post-effective Amendment to an S-8 Filing (s-8 Pos) Edgar (US Regulatory) - 5/14/2019 5:08:35 PM
Fred Kadiddlehopper   Wednesday, 04/24/19 09:03:21 AM
Re: None
Post # of 5689 
Halozyme Therapeutics Inc, Inst Holders, 1Q 2019 (HALO)
3:57 am ET April 20, 2019 (Dow Jones) Print

The following table shows the largest shareholders in HALOZYME THERAPEUTICS INC COM (HALO) for the quarter ended March 31, 2019, listed by holding size. The list represents up to 50 of the largest holders in the company.

Note: Unless otherwise mentioned the reporting date is 03/31/2019

Institution... Shares Held... %Held... Last Report

The Vanguard Group Inc. 13,207,753 154,094 9.090 12/31

BlackRock Fund Advisors 9,603,144 (96,106) 6.609 12/31

Iridian Asset Management LLC 9,027,164 (201,235) 6.213 12/31

Bellevue Asset Management AG 8,322,860 75,000 5.728 12/31

SSgA Funds Management Inc. 4,107,501 (235,667) 2.827 12/31

Invesco Advisers Inc. 3,744,719 51,368 2.577 12/31

Pictet Asset Management SA 3,715,808 347,674 2.557 12/31

Thrivent Investment Management 3,562,505 426,775 2.452 12/31

Snyder Capital Management LP 2,833,759 446,409 1.950 12/31

Fidelity Management & Research 2,556,359 176,900 1.759 12/31

First Eagle Investment Managem 2,130,775 (42,314) 1.466 12/31

JPMorgan Investment Management 2,040,243 411,833 1.404 12/31

Artisan Partners LP 2,039,215 (122,657) 1.403 12/31

JPMorgan Asset Management (UK) 1,881,386 132,920 1.295 12/31

Northern Trust Investments In 1,768,452 (53,074) 1.217 12/31

Merian Global Investors (UK) L 1,562,994 369,267 1.076 12/31

Geode Capital Management LLC 1,520,657 76,753 1.047 12/31

Goldman Sachs Asset Management 1,347,389 40,066 0.927 12/31

Dimensional Fund Advisors LP 1,097,080 294,909 0.755 12/31

New York State Common Retireme 1,048,054 29,284 0.721 12/31

Numeric Investors LLC 1,037,698 156,000 0.714 12/31

PanAgora Asset Management Inc 1,000,059 12,192 0.688 12/31

OppenheimerFunds Inc. 1,000,000 0 0.688 12/31

Granite Investment Partners LL 988,939 223,836 0.681 12/31

First Light Asset Management L 938,399 52,876 0.646 12/31

BlackRock Advisors LLC 902,306 23,648 0.621 12/31

Fisher Asset Management LLC 865,919 418,581 0.596 12/31

Elk Creek Partners LLC 740,816 139,123 0.510 12/31

Teachers Advisors LLC 735,938 413,847 0.506 12/31

Charles Schwab Investment Mana 695,083 (245,209) 0.478 03/31

Federated MDTA LLC 622,212 454,491 0.428 12/31

Goldman Sachs & Co. LLC (Priva 558,419 203,366 0.384 12/31

TIAA-CREF Investment Managemen 529,018 (9,662) 0.364 12/31

Macquarie Investment Managemen 500,000 0 0.344 12/31

Invesco Capital Management LLC 469,395 (16,707) 0.323 12/31

Two Sigma Advisers LP 455,020 (281,100) 0.313 12/31

BlackRock Investment Managemen 454,781 10,728 0.313 12/31

BlackRock Investment Managemen 439,958 (40,536) 0.303 12/31

AXA Investment Managers UK Ltd 428,217 0 0.295 12/31

American Century Investment Ma 416,996 217,379 0.287 12/31

D. E. Shaw & Co. LP 402,884 32,721 0.277 12/31

SV Health Managers LLP 398,633 (30,000) 0.274 12/31

SEI Investments Management Cor 376,339 0 0.259 12/31

ALPS Advisors Inc. 361,008 77,631 0.248 12/31

The Bank of New York Mellon Co 353,758 (49,635) 0.243 12/31

Jacobs Levy Equity Management 327,478 (23,500) 0.225 12/31

AllianceBernstein LP 315,610 26,786 0.217 12/31

Renaissance Technologies LLC 304,600 (286,000) 0.210 12/31

Baker Bros. Advisors LP 299,969 (150,000) 0.206 12/31

DWS Investment GmbH 283,916 (861,515) 0.195 12/31

13F data provided by: Factset Research Systems Inc.;

Please send questions to ownership@factset.com.

Copyright, Factset Research Systems, 2019. All Rights Reserved.

(END) Dow Jones Newswires

April 20, 2019 03:57 ET (07:57 GMT)

The more you know, the less you don't know.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist